Hiroyuki Ohigashi

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Early administration of calcineurin inhibitors limits tolerogenic effect of PTCy in allogeneic hematopoietic transplant.

Early administration of calcineurin inhibitors limits tolerogenic effect of PTCy in allogeneic hematopoietic transplant.

Journal: Blood

Published: July 24, 2025

Membranous nephropathy preceding Bing-Neel syndrome: successful treatment with tirabrutinib.

Membranous nephropathy preceding Bing-Neel syndrome: successful treatment with tirabrutinib.

Journal: Journal of nephrology

Published: April 30, 2025

Classical and Late-Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis.

Classical and Late-Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis.

Journal: American journal of hematology

Published: December 24, 2024

Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT.

Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT.

Journal: EJHaem

Published: November 06, 2024

Chronic graft-versus-host disease myelitis successfully treated with rituximab.

Chronic graft-versus-host disease myelitis successfully treated with rituximab.

Journal: International journal of hematology

Published: October 21, 2024

Increased Non-Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan-Based Regimen.

Increased Non-Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan-Based Regimen.

Journal: European journal of haematology

Published: September 24, 2024

Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT.

Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT.

Journal: Blood advances

Published: August 02, 2024

Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation.

Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation.

Journal: Cytotherapy

Published: July 22, 2024

Comparative outcomes of various transplantation platforms, highlighting haploidentical transplants with post-transplantation cyclophosphamide for adult T-cell leukaemia/lymphoma.

Comparative outcomes of various transplantation platforms, highlighting haploidentical transplants with post-transplantation cyclophosphamide for adult T-cell leukaemia/lymphoma.

Journal: British journal of haematology

Published: June 25, 2024

The optimal conditioning intensity of stem cell transplantation for acute myeloid leukemia in complete remission.

The optimal conditioning intensity of stem cell transplantation for acute myeloid leukemia in complete remission.

Journal: Annals of hematology

Published: June 19, 2024

Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease.

Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease.

Journal: International journal of hematology

Published: May 14, 2024

Associations between acute and chronic graft-versus-host disease.

Associations between acute and chronic graft-versus-host disease.

Journal: Blood advances

Published: April 22, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026